Patient preferences for treating refractory overactive bladder in the UK

@article{Hashim2015PatientPF,
  title={Patient preferences for treating refractory overactive bladder in the UK},
  author={Hashim Hashim and Kathleen Marie Beusterien and John F. P. Bridges and Kaitlan Amos and Linda Cardozo},
  journal={International Urology and Nephrology},
  year={2015},
  volume={47},
  pages={1619-1627}
}
To evaluate patient preferences for refractory overactive bladder (OAB) treatments: sacral neuromodulation (SNM), onabotulinum toxin A (Botox®), and percutaneous tibial nerve stimulation (PTNS). A cross-sectional Web survey was conducted with UK idiopathic OAB patients, recruited by a market research company. Preference was explored using direct questioning, comparing SNM, Botox, and PTNS, and via best–worst scaling (BWS). In BWS, patients prioritized subsets of 13 treatment characteristics… CONTINUE READING
5 Citations
24 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 24 references

the management of urinary incontinence in women [Internet], 2nd ed

  • Urinary incontinence in women
  • The Royal College of Obstetricians and…
  • 2015
Highly Influential
3 Excerpts

Patient defined goals of care in treatment of medication refractory overactive bladder

  • M Levy
  • Neurourol Urodyn
  • 2014
1 Excerpt

Patient satisfaction after intravesical botulinum toxin type a injection for refractory detrusor overactivity

  • H Imam
  • Neurourol Urodyn
  • 2011

Similar Papers

Loading similar papers…